Pooled Phase-3 Analysis of Efficacy and Safety of Estetrol/Drospirenone Combined Oral Contraceptive

      To examine efficacy and safety of a combined oral contraceptive pill containing the estetrol (E4) and drospirenone (DRSP) in a 24/4-day oral regimen.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect